Đang chuẩn bị liên kết để tải về tài liệu:
Effcacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: A multicenter, prospective, single-arm, phase 2 trial

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Pomalidomide in combination with dexamethasone has demonstrated positive results in patients with relapsed or refractory multiple myeloma (RRMM), but no data are available in China. We conducted a multicenter, single-arm trial to examine the efficacy and safety of bioequivalent generic pomalidomide plus low-dose dexamethasone in Chinese RRMM patients. |

TÀI LIỆU LIÊN QUAN

Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis

Effcacy of various core decompression techniques versus non-operative treatment for osteonecrosis of the femoral head: A systemic review and network meta-analysis of randomized controlled trials

Effcacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: A multicenter, prospective, single-arm, phase 2 trial

Effcacy of denosumab therapy for a 12-year-old female patient with Williams syndrome with osteoporosis and history of fractures: A case report